Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1.334 USD | -3.33% | -7.36% | -29.04% |
05-15 | HC Wainwright Adjusts IO Biotech Price Target to $12 From $8, Maintains Buy Rating | MT |
05-14 | IO Biotech, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-29.04% | 90.92M | |
+41.67% | 54.04B | |
+43.57% | 41.96B | |
-1.13% | 41.92B | |
-7.59% | 28.35B | |
+12.22% | 26.35B | |
-22.41% | 19B | |
+7.84% | 13B | |
+29.16% | 12.28B | |
+25.14% | 12.19B |
- Stock Market
- Equities
- IOBT Stock
- News IO Biotech, Inc.
- Morgan Stanley Starts IO Biotech at Overweight with $21 Price Target